Apollomics - Class A (APLM) closed at $19.90 on October 27, 2026, unchanged from the previous close, on volume of 491 shares (30-day average 9,237).
Data as of October 27, 2026.
Apollomics Announces $10 Million Private Placement Transaction
Globe Newswire (Tue, 11-Aug 4:35 PM ET)
Nasdaq Resumes Trading in Apollomics After Nearly a Month-Long Halt—What Could This Mean for APLM?
Market Chameleon (Wed, 15-Oct 5:37 AM ET)
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.
Apollomics - Class A trades on the NASDAQ stock market under the symbol APLM.
As of October 27, 2026, APLM stock price was flat at $19.90 with 491 million shares trading.
APLM has a market cap of $58.01 million. This is considered a Micro Cap stock.
In the last 3 years, APLM traded as high as $179.00 and as low as $3.66.
APLM has underperformed the market in the last year with a price return of -13.5% while the SPY ETF gained +14.8%. However, in the short term, APLM had mixed performance relative to the market. It has outperformed in the last 3 months, returning +9.3% vs +4.4% return in SPY. But in the last 2 weeks, APLM shares have been beat by the market, returning -6.7% compared to an SPY return of -1.1%.
APLM support price is $18.52 and resistance is $21.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APLM shares will trade within this expected range on the day.
